This Qualcomm Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Avi Kapoor 7 months ago
NewsDowngradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See what analysts think about QCOM stock.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Bernstein analyst Stacy Rasgon downgraded Qualcomm Inc (NASDAQ:QCOM) from Outperform to Market Perform and cut the price target from $175 to $140. Qualcomm shares closed at $130.35 on Wednesday. See how other analysts view this stock.
- Citizens analyst Silvan Tuerkcan downgraded Terns Pharmaceuticals Inc (NASDAQ:TERN) from Market Outperform to Market Perform. Terns Pharma shares closed at $52.86 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics Inc (NASDAQ:ADMA) from Overweight to Neutral. ADMA Biologics shares closed at $9.63 on Wednesday. See how other analysts view this stock.
- TD Cowen analyst Ritu Baral downgraded Terns Pharmaceuticals Inc (NASDAQ:TERN) from Buy to Hold and announces $53 price target. Terns Pharma shares closed at $52.86 on Wednesday. See how other analysts view this stock.
Considering buying QCOM stock? Here’s what analysts think:
Photo via Shutterstock